文献速递神经核医学肿瘤 PET/CT核素与放射性配体治疗

PSMA放射性配体摄取与高级别胶质瘤和脑转移瘤中PSMA表达相关:一项前瞻性PET-MRI引导多区域活检研究的启示

PSMA radioligand uptake correlates with PSMA expression in high-grade glioma and brain metastasis: insights from a prospective PET-MRI guided multiregional biopsy study.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2025-05-26

该前瞻性研究纳入12例高级别胶质瘤或脑转移瘤患者,行[68Ga]Ga-PSMA-11 PET-MRI后引导活检,分析PSMA摄取与肿瘤微环境PSMA表达的关系。结果显示所有患者肿瘤均有摄取,PSMA表达主要位于肿瘤微血管,在高级别胶质瘤中微血管PSMA表达与摄取显著相关(r=0.487,P<0.01),而肿瘤细胞表达不相关。

要点

  • 所有患者肿瘤均见[68Ga]Ga-PSMA-11摄取,SUVmax中位数10.5(范围4.7-19.8)。
  • PSMA强表达主要见于肿瘤微血管:高级别胶质瘤14/23(61%),脑转移瘤13/20(65%)。
  • 高级别胶质瘤中微血管PSMA表达与PET摄取显著相关(r=0.487,P<0.01),肿瘤细胞表达不相关。

核心结论

  • 脑肿瘤中PSMA表达主要为血管性,这很可能解释为何高级别胶质瘤中微血管而非肿瘤细胞PSMA表达与[68Ga]Ga-PSMA-11摄取相关。
  • 这种新生血管表达对未来基于PSMA的放射性配体治疗研究是关键信息,因为α发射体可能无法充分靶向肿瘤DNA。

研究设计与样本

  • 前瞻性研究,纳入12例高级别胶质瘤(胶质母细胞瘤6例、少突胶质细胞瘤1例)或脑转移瘤(肺癌4例、乳腺癌1例)患者。
  • 静脉注射[68Ga]Ga-PSMA-11(1.5 MBq/kg)后行PET-MRI,随后在(再)切除手术中行影像引导活检采样。
  • 从低和高[68Ga]Ga-PSMA-11摄取位置取多个样本(每患者中位数3个,高级别胶质瘤23个、脑转移瘤20个),用形态学和免疫组化分析血管及非血管结构PSMA表达。

主要发现

  • 所有患者肿瘤均显示[68Ga]Ga-PSMA-11摄取,SUVmax中位数10.5(范围4.7-19.8)。
  • 肿瘤微血管中见PSMA强表达:高级别胶质瘤14/23(61%),脑转移瘤13/20(65%)。
  • 肿瘤细胞PSMA表达见于部分高级别胶质瘤(10/23,其中强表达8/10)和脑转移瘤(3/20,均无强表达)。
  • 肿瘤中非恶性胶质细胞也见PSMA强表达;健康脑对照样本PSMA表达可忽略。
  • 高级别胶质瘤中[68Ga]Ga-PSMA-11摄取与肿瘤微血管PSMA表达显著相关(r=0.487,P<0.01),与肿瘤细胞PSMA表达不相关。

关键数值与推荐

  • PSMA强表达在肿瘤微血管:高级别胶质瘤14/23(61%),脑转移瘤13/20(65%)。
  • 肿瘤细胞PSMA表达:高级别胶质瘤10/23(强表达8/10),脑转移瘤3/20(无强表达)。
  • 高级别胶质瘤中摄取与微血管PSMA表达相关系数r=0.487,P<0.01。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Prostate-specific membrane antigen (PSMA) is a potential target for radioligand therapy (RLT) in neuro-oncology. This study investigates the direct relation between [68Ga]Ga-PSMA-11 uptake on PET and PSMA expression in the tumour micro-environment of high-grade glioma (HGG) and brain metastasis (BM). METHODS: Twelve patients with HGG (glioblastoma n = 6, oligodendroglioma n = 1), or BM (lung- n = 4, breast cancer n = 1), underwent PET-MRI after intravenous [68Ga]Ga-PSMA-11 injection (1.5 MBq/kg), followed by image-guided biopsy sampling during (re-)resection surgery. Multiple samples (median n = 3/patient, n = 23 HGG/n = 20 BM) from locations of low and high [68Ga]Ga-PSMA-11 uptake were analysed for PSMA expression in vasculature and non-vascular structures using morphology and immunohistochemistry. RESULTS: All patients showed [68Ga]Ga-PSMA-11 uptake in tumour ( SUVmax median, range: 10.5, 4.7-19.8). Strong PSMA expression was found in tumour microvasculature (14/23, 61% in HGG, 13/20, 65% in BM). Tumour cell PSMA expression was found in a subset of HGG (10/23; of which strong in 8/10) and BM (3/20; none of which showed strong expression). Strong PSMA expression was also found on non-malignant glial cells in tumour. PSMA expression in healthy brain control samples was negligible. In HGG, a significant correlation existed between [68Ga]Ga-PSMA-11 uptake and PSMA expression in tumour microvasculature (r = 0.487, P < 0.01), but not tumour cells. CONCLUSION: PSMA expression in brain tumours is predominately vascular, which likely explains why microvascular (rather than tumour cell) PSMA expression correlates with [68Ga]Ga-PSMA-11 uptake in HGG. This neovascular expression is crucial information for future PSMA-based RLT studies, as alpha-emitters may not sufficiently target tumour DNA. NCT05798273; date of registration: 1/9/2020.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Pruis IJ, van Dis V, Maas SLN, et al. PSMA radioligand uptake correlates with PSMA expression in high-grade glioma and brain metastasis: insights from a prospective PET-MRI guided multiregional biopsy study. Eur J Nucl Med Mol Imaging. 2025. PMID: 40414994. doi:10.1007/s00259-025-07338-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。